Thursday, December 07, 2006

VNDA

Vanda Pharmaceuticals Inc. phase 3 study of schizophrenia drug Iloperidone shows positive results. This stock will be active in trading today so put it on that trading radar.

Budd Foxx

0 Comments:

Post a Comment

<< Home